We screened 1,625 patients who were enrolled onto the Austrian and German ALL-Berlin-Frankfurt-M?nster (ALL-BFM) trials 86, 90, 95, and 2000 with ETV6/RUNX1-specific fluorescent in situ hybridization probes, and we identified 29 patient cases (2%) who had an iAMP21. 